Nuveen’s Natus Medical Inc NTUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-441,716
Closed -$14.5M 3315
2022
Q2
$14.5M Sell
441,716
-369,500
-46% -$11.7M 0.01% 1273
2022
Q1
$20.5M Sell
811,216
-9,346
-1% -$228K 0.01% 1181
2021
Q4
$19.5M Sell
820,562
-68,676
-8% -$1.69M 0.01% 1245
2021
Q3
$22.3M Sell
889,238
-10,933
-1% -$279K 0.01% 1192
2021
Q2
$23.4M Sell
900,171
-300,646
-25% -$8.18M 0.01% 1243
2021
Q1
$30.8M Buy
1,200,817
+64,643
+6% +$1.66M 0.01% 1018
2020
Q4
$22.8M Buy
1,136,174
+242,096
+27% +$4.74M 0.01% 1177
2020
Q3
$15.3M Sell
894,078
-13,421
-1% -$254K 0.01% 1227
2020
Q2
$19.8M Buy
907,499
+31,797
+4% +$728K 0.01% 1054
2020
Q1
$20.3M Sell
875,702
-196,367
-18% -$5.71M 0.01% 894
2019
Q4
$35.4M Buy
1,072,069
+79,550
+8% +$2.55M 0.01% 857
2019
Q3
$31.6M Sell
992,519
-17,845
-2% -$520K 0.01% 891
2019
Q2
$26M Buy
1,010,364
+122,690
+14% +$3.13M 0.01% 1009
2019
Q1
$22.5M Buy
887,674
+83,483
+10% +$2.49M 0.12% 280
2018
Q4
$27.4M Sell
804,191
-34,160
-4% -$1.11M 0.17% 177
2018
Q3
$29.9M Buy
838,351
+26,952
+3% +$952K 0.16% 200
2018
Q2
$28M Buy
811,399
+312,545
+63% +$11M 0.18% 176
2018
Q1
$16.8M Buy
498,854
+469,502
+1,600% +$14.9M 0.11% 278
2017
Q4
$1.12M Sell
29,352
-108
-0.4% -$4.31K 0.01% 717
2017
Q3
$1.1M Buy
29,460
+10,013
+51% +$353K 0.01% 739
2017
Q2
$725K Buy
19,447
+9,366
+93% +$338K ﹤0.01% 832
2017
Q1
$396K Buy
+10,081
New +$378K ﹤0.01% 1213

Other funds holding NTUS

Nuveen's NTUS Position: Q3 2022 in Review

Nuveen sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 441,716 shares — an estimated $14.5M sold.

Nuveen first reported a position in NTUS in Q1 2017 and held it in 22 quarters. The position peaked at $35.4M in Q4 2019. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.

  • Nuveen reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
  • Nuveen sold 441,716 Natus Medical Inc shares in Q3 2022, an estimated $14.5M.
  • Nuveen first reported a position in Natus Medical Inc in Q1 2017 and held it in 22 quarters.
  • Nuveen's Natus Medical Inc position peaked at $35.4M in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.

Based on Nuveen's 13F filing for Q3 2022, filed 14 Nov 2022.